Radiopharmaceutical Theranostics Market Scope And Analysis

  • Report Code : TIPRE00024328
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 185
Buy Now

Radiopharmaceutical Theranostics Market Analysis, Scope, and Growth by 2028

Buy Now

Radiopharmaceutical Theranostics Market Report Radiopharmaceutical Theranostics Market Size and Share Radiopharmaceutical Theranostics Market Scope and Analysis

Radiopharmaceutical Theranostics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1.81 Billion
Market Size by 2028 US$ 3.44 Billion
Global CAGR (2022 - 2028) 11.3%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Product Type
  • Alpha Emitters
  • Beta Emitters
  • Positron Emission Tomography Tracers
By Radioisotope
  • Technetium-99
  • Gallium-68
  • Iodine-131
  • Iodine-123
  • 18F
  • Y-90
  • Lutetium 177
  • Copper 67
  • Copper 64
By Source
  • Nuclear Reactors
  • Cyclotrons
By Application
  • Targeted Therapeutic
  • Companion Diagnostic
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bayer AG
  • GE HealthCare Technologies Inc
  • Curium
  • Lantheus Medical Imaging Inc
  • Telix Pharmaceuticals Ltd
  • Cardinal Health Inc
  • Advanced Accelerator Applications S A
  • Jubilant Radiopharma
  • Theragnostics

    • Company Profiles - Radiopharmaceutical Theranostics Market

    • Bayer AG
    • GE HealthCare Technologies Inc
    • Curium
    • Lantheus Medical Imaging, Inc.
    • Telix Pharmaceuticals Ltd.
    • Cardinal Health Inc
    • Advanced Accelerator Applications S.A.
    • Jubilant Radiopharma
    • Theragnostics
    • NuView Life Sciences